NTP is a leading global producer and supplier of I-131.
Iodine-131 (I-131) is a radioactive isotope of iodine that is used in nuclear medicine procedures to diagnose and treat conditions of the thyroid, including hyperthyroidism and thyroid cancer.
I-131 is a fission product of uranium-235. During the Mo-99 production process, I-131 is extracted and purified, yielding a top quality product for sale to customers in bulk quantities.
As a supplier of fission I-131, NTP has the unique advantage of having control over almost the entire production and marketing cycle – from target irradiation to radiochemical production, dispensing, global distribution, and waste management.
Our high-flux reactor SAFARI-1 operates about 300 days each year and our on-site processing facilities run 24-hour shifts, 365 days a year. With a dedicated transport and logistics service delivering our products around the world, safely and on time, NTP provides one of the most reliable and trusted sources of commercial I-131.
NTP Radioisotopes supplies the world’s largest nuclear medicine, medical imaging and radiopharmaceutical companies including GE Healthcare, IBA Molecular and Mallinckrodt.
Atomic information: Iodine-131
Isotope name: iodine-131
Appearance: Transparent liquid
Half-life: 8.04 days
Emits: Beta and gamma radiation
Used in: Diagnosis and treatment of thyroid conditions
Decays to: xenon-131